Padagis US LLC is recalling 10,872 jars of Triamcinolone Acetonide Cream USP, 0.025% (triamcinolone acetonide). Long-term stability testing revealed that the medication was not meeting potency specifications, resulting in jars that could be either subpotent (too weak) or superpotent (too strong). The recall affects prescription 1 lb (454 g) jars sold under NDC 45802-0063-05.
A subpotent drug may not effectively treat the underlying skin condition, while a superpotent drug can increase the risk of side effects from the corticosteroid. No incidents or injuries have been reported to date.
You have 2 options:
Rx Only. Manufactured By Padagis, Minneapolis, MN 55427.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.